

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Aducanumab ngumuthi kadokotela oklanyelwe ukwelapha isifo i-Alzheimer's ngokugxila kuma-amyloid beta plaques ebuchosheni. Inikezwa nge-intravenous (IV) infusion endaweni yokunakekelwa kwezempilo futhi imelela enye yezindlela zokwelapha zokuqala ezivunyelwe ngokuqondile ukubhekana nenqubo yesifo esiyisisekelo se-Alzheimer's kunokumane kuphethe izimpawu.
Lo muthi udale ukunakwa okukhulu emphakathini wezokwelapha ngoba uthatha indlela ehlukile yokwelapha isifo i-Alzheimer's. Ngenkathi eminye imithi igxila ekusizeni ngezimpawu zenkumbulo nokucabanga, i-aducanumab isebenza ngokuzama ukususa izinto eziyingozi zamaprotheni eziqongelela ebuchosheni babantu abanesifo i-Alzheimer's.
I-Aducanumab ngumuthi we-monoclonal antibody ogxila kuma-amyloid beta plaques ebuchosheni. Lawa ma-plaques yizinto ezinamathelayo zamaprotheni eziqongelela ebuchosheni babantu abanesifo i-Alzheimer's futhi okucatshangwa ukuthi anomthelela ekuqhubekeleni phambili kwalesi simo.
Lo muthi ukhiqizwa njenge-Aduhelm yi-Biogen futhi wathola imvume ye-FDA ngo-2021. Yenzelwe ngokuqondile abantu abanokukhubazeka okuncane kokuqonda noma i-dementia encane ngenxa yesifo i-Alzheimer's. Lo muthi usebenza ngokubopha kuma-amyloid beta proteins futhi usiza amasosha omzimba ukuthi asuse lezi zinto eziyingozi emathanjeni obuchopho.
Lokhu kwelashwa kumelela ushintsho olukhulu ekunakekelweni kwe-Alzheimer's ngoba ngumuthi wokuqala ovunyelwe ohloselwe ukunciphisa ukuqhubeka kwalesi sifo kunokumane welaphe izimpawu. Kodwa-ke, kubalulekile ukuqonda ukuthi i-aducanumab akuyona ikhambi lesifo i-Alzheimer's.
I-Aducanumab ivunyelwe ngokuqondile ukwelapha ukukhubazeka okuncane kokuqonda kanye ne-dementia encane ebangelwa isifo i-Alzheimer's. Yenzelwe abantu abasezigabeni zokuqala zalesi simo abasenenkululeko ethile emisebenzini yabo yansuku zonke.
Udktela wakho ngokuvamile uzoncoma lo muthi uma uqinisekisile ukuthi une-amyloid beta plaques ebuchosheni bakho, okungatholakala ngezithombe zobuchopho ezikhethekile noma izivivinyo zoketshezi lomgogodla. Lo muthi awulungele abantu abanesifo i-Alzheimer's esiphakathi nendawo kuya kwesinzima, njengoba izifundo zomtholampilo zigxile ezigabeni zokuqala zalesi simo.
Umgomo wokwelashwa ukwehlisa ukuqhubeka kokwehla kwengqondo nokugcina amakhono okucabanga isikhathi eside ngangokunokwenzeka. Ngenkathi lo muthi ungase usize ukunciphisa ama-amyloid plaques ebuchosheni, izinzuzo zomtholampilo mayelana nokuthuthukiswa kwenkumbulo nokucabanga ziye zaxoxwa phakathi kwabahlinzeki bezempilo.
I-Aducanumab isebenza ngokugxila nokubopha kuma-amyloid beta plaques aqongelela ebuchosheni babantu abanesifo i-Alzheimer's. Cabanga ngala ma-plaques njengemfucumfucu eyingozi ephazamisa ukuxhumana okujwayelekile kwamaseli obuchopho nokusebenza kwawo.
Uma lo muthi usubophele kulawa ma-plaques, uthumela isignali ohlelweni lomzimba wakho lokuzivikela ukuba lusize ukuwasusa. Le nqubo ibizwa ngokuthi i-immunotherapy, lapho umuthi empeleni ufundisa uhlelo lwakho lokuzivikela ukuba luqaphele futhi lususe lezi zinto eziyingozi zamaprotheni ngempumelelo enkulu.
Lo muthi ubhekwa njengokwelashwa okuqondiwe ngoba lugxila esicini esithile se-Alzheimer's disease pathology. Kodwa-ke, kubalulekile ukuqonda ukuthi le yindlela entsha, futhi abacwaningi basafunda ukuthi yiziphi izinzuzo zomtholampilo ezigulini ezingase zizithole ekususweni kwama-plaque.
I-Aducanumab inikezwa kuphela ngomjovo we-intravenous endaweni yokunakekelwa kwezempilo, ngokuvamile esibhedlela noma esikhungweni esikhethekile sokufaka imithi. Awukwazi ukuthatha lo muthi ekhaya, njengoba kudinga ukuqapha ngokucophelela ochwepheshe bezempilo abaqeqeshiwe.
Inqubo yokufaka umuthi ithatha cishe ihora elilodwa, futhi uzodinga ukubhekwa okungenani ihora elilodwa ngemuva ukuze kuqashwe noma yiziphi izindlela zokuphendula ngokushesha. Ithimba lakho lokunakekelwa kwezempilo lizohlola izimpawu zakho ezibalulekile futhi libheke noma yiziphi izimpawu ezikhathazayo ngesikhathi nangemva kokwelashwa.
Ngaphambi kokufakwa komuthi ngamunye, kungase kudingeke ukuthi uthathe imithi yangaphambi kokwelashwa ukusiza ekuvikeleni izindlela zokuphendula zokufaka umuthi. Lokhu kungabandakanya ama-antihistamines noma imithi yokunciphisa ukuvuvukala. Umhlinzeki wakho wezempilo uzoxoxa ngalokhu nawe futhi aqinisekise ukuthi uzizwa ukhululekile kuyo yonke inqubo.
Akudingeki ukuthi uzile ukudla ngaphambi kokufakwa komuthi wakho, kodwa kungumqondo omuhle ukudla ukudla okulula ngaphambi kwesikhathi futhi uhlale unamanzi kahle. Ukugqoka izingubo ezikhululekile nokuletha okuthile okuzokugcina umatasa ngesikhathi sokufakwa komuthi kungasiza ukwenza ukuzizwela kujabulise kakhulu.
Ubude bokwelashwa nge-aducanumab buyahluka ngokuya ngempendulo yakho kanye nokubekezelelana komuntu ngamunye emuthini. Njengamanje, akukho ndawo yokuphela ejwayelekile yokwelashwa, njengoba lokhu kuyindlela yokwelapha entsha ngokuqhathaniswa yesifo i-Alzheimer.
Udokotela wakho uzoqapha eduze inqubekela phambili yakho ngokusebenzisa ukuskena kobuchopho njalo, ukuhlolwa kokuqonda, kanye nokuhlolwa kwempilo yonke. Lokhu kuqokwa kusiza ukunquma ukuthi imithi inikeza inzuzo nokuthi iphephile yini ukuthi uqhubeke nokwelashwa.
Ukwelashwa kuvame ukuqhubeka uma nje ubekezelela kahle imithi futhi ithimba lakho lokunakekelwa kwezempilo likholelwa ukuthi linikeza inzuzo. Abanye abantu bangase badinge ukumisa noma bayeke ukwelashwa uma bethuthukisa imiphumela engemihle ekhathazayo, ikakhulukazi ukuvuvukala kobuchopho noma ukopha.
Isinqumo sokuqhubeka noma sokuyeka ukwelashwa kufanele senziwe ngaso sonke isikhathi ngokubambisana nomhlinzeki wakho wezempilo, ucabangela impilo yakho yonke, izinga lempilo, kanye nemigomo yokwelashwa. Ukuxhumana njalo nethimba lakho lezokwelapha kubalulekile kuyo yonke indlela yakho yokwelashwa.
Njengazo zonke izidakamizwa, i-aducanumab ingabangela imiphumela emibi, kusukela kokulula kuya kokukhulu. Ukuqonda lezi zimo ezingase zibe khona kungakusiza ukuthi uzizwe ulungiseleleke kakhulu futhi wazi ukuthi ungaxhumana nini nomhlinzeki wakho wezempilo.
Imiphumela emibi evame kakhulu ongase uyithole ihlanganisa ikhanda, ukudideka, isiyezi, nesicanucanu. Lezi zimpawu zivame ukuba lula futhi zingase zithuthuke njengoba umzimba wakho uzivumela ukwelashwa ngokuhamba kwesikhathi.
Nawa amanye emiphumela emibi evame kakhulu ukubikwa iziguli:
Ngenkathi le miphumela emibi ejwayelekile ingaba ngaphandle kokunethezeka, ngokuvamile ayidingi ukuyeka ukwelashwa futhi ingavame ukuphathwa ngokunakekelwa okusekelayo nesikhathi.
Nokho, kunemiphumela emibi engathi sína edinga ukunakekelwa kwezempilo ngokushesha, ikakhulukazi isimo esibizwa nge-ARIA (Amyloid-Related Imaging Abnormalities). Lokhu kuhilela ukuvuvukala kobuchopho noma izindawo ezincane zokopha ezingatholakala ekuskeneni kobuchopho.
Nawa amanye emiphumela emibi engathi sína edinga ukunakekelwa kwezempilo ngokushesha:
Le miphumela emibi engathi sína ayivamile kodwa ingaba yingozi, yingakho ukuqapha ubuchopho njalo ngokuskena kwe-MRI kuyingxenye ebalulekile yohlelo lwakho lokwelashwa.
Izinkinga ezingavamile kodwa ezingathi sína zingabandakanya ukusabela okukhulu komzimba ngesikhathi sokufakwa, ukuvuvukala okukhulu kobuchopho okubangela izimpawu, futhi ezimweni ezingavamile kakhulu, ukopha okukhulu ebuchosheni. Ithimba lakho lokunakekelwa kwezempilo liqeqeshwe ukubona nokuphatha lezi zinkinga uma zenzeka.
I-Aducanumab ayifanele wonke umuntu onesifo i-Alzheimer. Umhlinzeki wakho wokunakekelwa kwezempilo uzohlola ngokucophelela ukuthi lo muthi ulungile yini esimweni sakho esithile.
Abantu abanesifo i-Alzheimer esiphakathi nendawo kuya kwesibi akufanele bathole i-aducanumab, njengoba izifundo zomtholampilo zihlanganisa kuphela iziguli ezinokukhubazeka okuncane kokuqonda noma i-dementia encane. Umuthi awukabonakali usebenza ezigabeni ezithuthukisiwe zesifo.
Akufanele uthole i-aducanumab uma wazi ukuthi unokungezwani komzimba nomuthi noma yiziphi izingxenye zawo. Ngaphezu kwalokho, abantu abanezifo ezithile zokuphuma igazi noma labo abathatha imithi ethile yokunciphisa igazi kungenzeka bangabi ngabazongenela ukwelashwa.
Nazi izimo nezimo lapho i-aducanumab inganconwa khona:
Udokotela wakho uzobuye acabangele impilo yakho yonke, eminye imithi oyithathayo, kanye nekhono lakho lokuthatha ukuqapha njalo lapho enquma ukuthi i-aducanumab ilungele yini wena.
Abantu abangakwazi ukuthatha ukuskena kwe-MRI okuvamile ngenxa yokufakelwa kwezokwelapha noma i-claustrophobia enkulu kungenzeka bangabi ngabazongenela, njengoba ukuqapha ubuchopho kuyingxenye ebalulekile yokwelashwa okuphephile ngalo muthi.
I-Aducanumab ithengiswa ngaphansi kwegama lomkhiqizo elithi Aduhelm, elenziwe yi-Biogen. Leli njengamanje yilona kuphela igama lomkhiqizo elitholakala ngalo muthi e-United States.
Igama eliphelele elivamile lithi aducanumab-avwa, okusiza ukuthi lihlukaniswe nezinye izindlela ezingase zithuthukiswe esikhathini esizayo. Uma ukhuluma ngalo muthi nomhlinzeki wakho wezempilo noma usokhemisi, ungaqhubeka ukuwubiza nganoma yiliphi igama.
I-Aduhelm itholakala kuphela ngezikhungo zezempilo ezikhethekile futhi idinga ukuphathwa okukhethekile nezinqubo zokuphatha. Awukwazi ukuthola lo muthi ngemithi ejwayelekile yokuthengisa, njengoba kufanele ulungiswe futhi unikezwe ezindaweni zomtholampilo.
Njengamanje, zikhona ezinye izindlela ezilinganiselwe ze-aducanumab zokuhlasela ama-amyloid plaques esifo i-Alzheimer. Kodwa-ke, kukhona eminye imithi etholakalayo ukusiza ukuphatha izimpawu ze-Alzheimer, yize isebenza ngendlela ehlukile kune-aducanumab.
Imithi yendabuko ye-Alzheimer ihlanganisa izithiyo ze-cholinesterase njenge-donepezil (Aricept), rivastigmine (Exelon), kanye ne-galantamine (Razadyne). Le mithi isiza ngezimpawu zenkumbulo nokucabanga kodwa ayihlaseli inqubo yesifo esingaphansi njengoba i-aducanumab yenza.
Enye inketho yi-memantine (Namenda), esebenza ngokulawula umsebenzi wamakhemikhali obuchopho futhi ingasiza ngezimpawu ze-Alzheimer eziphakathi nendawo kuya kwezinzima. Abanye abantu bathatha inhlanganisela yale mithi kuye ngesigaba sesifo sabo nezidingo zomuntu ngamunye.
Muva nje, omunye umuthi oqondiswe ku-amyloid obizwa ngokuthi i-lecanemab (Leqembi) nawo uthole ukugunyazwa yi-FDA. Lo muthi usebenza ngendlela efanayo ne-aducanumab ngokuhlasela ama-amyloid plaques kodwa ukhombise imiphumela ehlukene yokuhlolwa komtholampilo.
Umhlinzeki wakho wezempilo angakusiza ukuthi uqonde ukuthi iyiphi indlela yokwelapha engase ifaneleke kakhulu esimweni sakho esithile, ucabangela isigaba sesifo sakho, impilo yonke, nezintandokazi zokwelashwa.
Ukuqhathanisa i-aducanumab ne-lecanemab kuyinkimbinkimbi ngoba yomibili imithi iqondise ama-amyloid plaques kodwa ibonise imiphumela ehlukene ezivivinyweni zomtholampilo. Akukho muthi othi ngokuqinisekile "ungcono" kunomunye, njengoba ukukhetha kuncike ezintweni zomuntu ngamunye.
I-Lecanemab ibonise ubufakazi obuqhubekayo bokunciphisa ukwehla kokuqonda ezivivinyweni zomtholampilo, kuyilapho izinzuzo zomtholampilo ze-aducanumab ziye zaba nempikiswano enkulu emphakathini wezokwelapha. Kodwa-ke, yomibili imithi inezingozi ezifanayo, ikakhulukazi amathuba okuvuvukala kobuchopho nokopha.
Amaphrofayili emiphumela emibi yomibili imithi afana kakhulu, ne-ARIA (ukuqubuka kobuchopho noma ukopha) okuyinto ekhathazayo kuzo zombili izindlela zokwelapha. Imvamisa nobukhulu bale miphumela emibi kungahluka kancane phakathi kwemithi emibili.
Umhlinzeki wakho wezempilo uzocabangela izici eziningana lapho ekhetha phakathi kwalezi zinketho, okuhlanganisa izici zakho ezithile zesifo, ezinye izimo zempilo, kanye nezintandokazi zakho mayelana nemigomo yokwelapha nezidingo zokuqapha.
Yomibili imithi idinga ukuqapha kobuchopho njalo futhi inikezwa ngokufakwa kwe-IV, ngakho ulwazi lokwelashwa lufana kakhulu. Isinqumo sivame ukwehla ekutheni imuphi umuthi udokotela wakho akholelwa ukuthi ufaneleka kakhulu ngokuya ngocwaningo lwamanje nesimo sakho sezokwelapha.
I-Aducanumab ingasetshenziswa kubantu abanezifo zenhliziyo, kodwa lokhu kudinga ukuhlolwa ngokucophelela yithimba lakho lezempilo. Umuthi ngokwawo awuthinti ngokuqondile ukusebenza kwenhliziyo, kodwa inqubo yokufaka kanye nemiphumela emibi engase ibe khona idinga ukucatshangelwa.
Abantu abanomfutho wegazi ophezulu ongagadiwe bangase badinge ukuba umfutho wabo wegazi ulawulwe ngcono ngaphambi kokuqala unyango, njengoba umfutho wegazi ophezulu unokunyusa umngcipheko wemiphumela emibi ehlobene nobuchopho. Udokotela wakho wezifo zenhliziyo kanye nodokotela wezifo zemizwa bazosebenzisana ukuze banqume ukuthi unyango lufanele yini.
Inqubo yokufaka umuthi ihlanganisa ukuqapha izimpawu zakho ezibalulekile, okusiza ukuqinisekisa ukuthi inhliziyo yakho ihlala izinzile ngesikhathi sonyango. Uma unesifo senhliziyo, ithimba lakho lokunakekelwa kwezempilo lingase lifune ukukuqapha eduze ngesikhathi nangemva kokufakwa komuthi.
Njengoba i-aducanumab inikezwa endaweni yokunakekelwa kwezempilo, imithamo ephuthelwe ngokuvamile ilawulwa yithimba lakho lezokwelapha. Uma uphuthelwa isikhathi sokuqokwa sokufakwa komuthi, xhumana nomhlinzeki wakho wokunakekelwa kwezempilo ngokushesha ngangokunokwenzeka ukuze uhlele kabusha.
Isikhathi somthamo wakho olandelayo sizoxhomeka ekutheni sekunesikhathi esingakanani kusukela ekufakweni komuthi kwakho kokugcina nokuthi ukuphi esimisweni sakho sonyango. Udokotela wakho angase alungise isikhathi kancane ukuze agcine iphethini yokwelapha ephumelela kakhulu.
Ungazami ukuthi "ulungise" umthamo ophuthelwe ngokuhlela imithamo eduze. Ithimba lakho lokunakekelwa kwezempilo lizinquma indlela ephephe kakhulu yokubuyela emgqeni ngeshejuli yakho yokwelapha.
Uma uthola noma yiziphi izimpawu ezikhathazayo ngesikhathi sokufakwa kwakho kwe-aducanumab, yazisa ngokushesha ithimba lakho lokunakekelwa kwezempilo. Ukufakwa komuthi kungancishiswa noma kumiswe okwesikhashana ngenkathi izimpawu zakho zihlolwa futhi zilawulwa.
Ukuphendula okujwayelekile kokufakwa komuthi njengekhanda elibuhlungu elingathí sina noma isicanucanu ngokuvamile kungalawulwa ngemithi nangokulungisa izinga lokufakwa komuthi. Ukuphendula okungathi sína kungase kudingeke ukumisa ukufakwa komuthi nokuhlinzeka ngonyango olwengeziwe lwezokwelapha.
Ithimba lakho lokunakekelwa kwezempilo liqeqeshwe ukubona nokulawula ukusabela kokufakwa komuthi, futhi linemithi nemishini etholakalayo kalula ukuze kubhekwane nanoma yiziphi izinkinga ezingase zivele ngesikhathi sonyango wakho.
Isinqumo sokuyeka ukwelashwa nge-aducanumab kufanele senziwe ngaso sonke isikhathi ngokubonisana nomhlinzeki wakho wezempilo. Akukho ukuphela okubekiwe kokwelashwa, njengoba lokhu kuncike ekuphenduleni kwakho komuntu ngamunye kanye nokubekezelela imithi.
Ungase uyeke ukwelashwa uma uba nemiphumela emibi engaxazululeki, uma ukuskena kobuchopho kubonisa izinguquko ezikhathazayo, noma uma wena nodokotela wakho ninquma ukuthi izingozi zidlula izinzuzo ezingaba khona. Abanye abantu bangase futhi bakhethe ukuyeka uma bezwa ukuthi ukwelashwa akunikezi inzuzo eqondakalayo.
Ukuqokwa okuvamile kokuqapha kusiza ithimba lakho lezempilo ukuthi lihlole ukuthi ukuqhubeka nokwelashwa kufanelekile yini. Lokhu kuhlola kucabangela ukusebenza kwakho kwengqondo, imiphumela yokuskena kobuchopho, imiphumela emibi, kanye nekhwalithi yempilo yakho iyonke.
Yebo, abantu abaningi baqhubeka nokuthatha eminye imithi ye-Alzheimer efana ne-donepezil, rivastigmine, noma i-memantine kanye ne-aducanumab. Le mithi isebenza ngezindlela ezihlukene futhi ingasetshenziswa ngokuphepha ndawonye.
Umhlinzeki wakho wezempilo uzobuyekeza yonke imithi yakho ukuze aqinisekise ukuthi akukho ukuxhumana okukhathazayo. Eminye imithi ethinta ingozi yokuphuma igazi noma ukusebenza komzimba okungavikelekile kungase kudingeke ukuthi kulungiswe noma kuqashwe eduze.
Kubalulekile ukugcina ithimba lakho lezempilo linolwazi ngayo yonke imithi, izithasiselo, kanye nemikhiqizo etholakala ngaphandle kwekhawunta oyithathayo, njengoba lezi ngezinye izikhathi zingasebenzisana ne-aducanumab noma zithinte ukuqapha kwakho ukwelashwa.
Get clear medical guidance
on symptoms, medications, and lab reports.
Download August today. No appointments. Just answers you can trust.